Abstract
Introduction: Amidst the global effort to curb cross-border transmission of COVID-19, numerous nations enforced international travel restrictions. One example is Taiwan, which witnessed an 85%-90% reduction in international travel during 2020-2022 compared with the preceding decade's average. Consequently, sales of duty-free cigarettes plummeted by approximately 90%. Objectives: This study leverages the virtual elimination of duty-free cigarette sales during the COVID-19 pandemic in Taiwan as a natural experiment to scrutinise the impact of banning such sales on cigarette consumption. The focus is on whether the drastic reduction in duty-free sales was compensated by an increase in taxed cigarette sales. Methods: We analysed trends in sales of both duty-free and taxed cigarettes, using data from Taiwan Ministry of Finance and Customs Administration between 2010 and 2023. We used quadratic regression models to fit historical taxed and duty-free sales data from 2010 to 2019. Subsequently, we projected total sales between 2020 and 2023 under a business-as-usual scenario where no travel ban occurred and duty-free sales were not disrupted. Results: The virtual eradication of duty-free cigarette sales was only partially offset by an upturn in taxed cigarette sales. The sales projected under the business-as-usual scenario consistently exceed the actual observations, with real data falling below the lower bound of the 95% CI in both 2021 and 2022. Conclusions: Duty-free tobacco sales associated with international travel should be abolished for the benefit of both public health and government tax revenue.
| Original language | English |
|---|---|
| Article number | tc-2025-059650 |
| Journal | Tobacco Control |
| Early online date | 5 Oct 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 5 Oct 2025 |
Bibliographical note
JRB owns 10 shares in Imperial Brands for research purposes. The shares were a gift from a public health campaigner and are not held for financial gain or benefit. All dividends received are donated to health-related charities and proceeds from any future share sale or takeover will be similarly donated. JRB is also a Senior Editor with Tobacco Control. He had no role in editorial decisions or handling peer review for this manuscript and recused themselves from any discussion about it. The authors have no other conflicts of interest relevant to this article to disclose.Data Availability Statement
All the data used in the study can be freely downloaded from https://osf.io/2juh7/?view_only=4dcd38b3d845479caaae5846e604b457Funding
This study was partially supported by Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare (Grant number 113FRP-23). JRB receives funding from Bloomberg Philanthropies, as part of the Bloomberg Initiative to Reduce Tobacco Use (www.bloomberg.org). The views expressed in this publication are those of the authors, as the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
| Funders | Funder number |
|---|---|
| Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare | |
| Ministry of Health and Welfare | 113FRP-23 |
Keywords
- Tobacco
- Taxation
- COVID
- Duty-Free
- Taiwan